Universal Health Services, Inc. provided earnings guidance for the year ending December 31, 2024. For the period, the company's net revenues are estimated to be approximately $15.411 billion to $15.706 billion representing an increase of 7.9% to 10.0% over 2023 net revenues of $14.282 billion. EPS-diluted range is estimated to be $13.00 per diluted share to $14.00 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.1 USD | +0.58% | +5.46% | +8.93% |
Apr. 26 | Leerink Partners Adjusts Price Target on Universal Health Services to $195 From $192 | MT |
Apr. 26 | Deutsche Bank Adjusts Price Target on Universal Health Services to $208 From $203 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.93% | 11.18B | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- UHS Stock
- News Universal Health Services, Inc.
- Universal Health Services, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024